Sign In
Buy OBSV
$0.102
+0 (+0%)
At Close: Jun 21, 2023
7 Penny Stocks That Actually Have Buy Ratings
01:22pm, Wednesday, 03'rd Feb 2021
Many penny stocks are destined to fail, but these seven penny stocks may succeed. Wall Street has buy recommedations on them.
7 Penny Stock Bubbles That Are About to Burst
12:33pm, Thursday, 28'th Jan 2021
There's an old saying that 'gaps refill'. And that means that these 7 penny stock Bubbles may be about to burst.
ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares
01:00am, Thursday, 28'th Jan 2021Implied Volatility Surging for ObsEva (OBSV) Stock Options
09:47am, Tuesday, 19'th Jan 2021
Investors need to pay close attention to ObsEva (OBSV) stock based on the movements in the options market lately.
OBSV Stock Price Increased 61.51%: Why It Happened
06:28am, Monday, 18'th Jan 2021
The stock price of Obseva SA (NASDAQ: OBSV) has increased by 61.51% on Friday, January 15. This is why it happened.
OBSV Stock: 7 Things for ObsEva Investors to Know Before Investing in the Penny Stock
11:45am, Friday, 15'th Jan 2021
ObsEva (OBSV) stock is soaring higher on Friday as shares see heavy trading despite there not being any noteworthy news today. The post OBSV Stock: 7 Things for ObsEva Investors to Know Before Investi
7 Stocks to Buy With That Second Stimulus Check As More Plan to Save It
05:21am, Thursday, 14'th Jan 2021
In the last round, 36% of recipients saved the money, If you're planning the same with the second payment, here are seven stocks to buy with your stimulus check. The post 7 Stocks to Buy With That Sec
ObsEva Provides Update on Yselty® (Linzagolix) Clinical Development Program
01:00am, Monday, 11'th Jan 2021
Geneva, Switzerland and Boston, MA – December 1, 2020 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve w
ObsEva SA to present at Jefferies Virtual London Healthcare Conference, November 17 – 19, 2020
01:00am, Friday, 13'th Nov 2020
Geneva, Switzerland and Boston, MA – November 13, 2020 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve
